Study shows stem cell therapy is safe for stroke patients; may aid recovery if given early. A multi-center trial looking at whether a single dose of millions of adult, bone-marrow-derived stem cells can aid stroke
Bio-pharmaceutical TiGenix has announced that their human stem cell treatment for patients that experienced a coronary attack was successful. The heart attack treatment uses allogenic cardiac stem cells in order to repair damaged heart muscle.
Stem cells treatments are approaching a more routine form of therapy thanks to researchers evaluating bioluminescent techniques in Sydney Australia. The Aussie research team along with the Heart Research Institute in Sydney has devised an